Marcelo Berlim is mainly interested in the study and treatment of depressive disorders with the use of state-of-the-art neuromodulation techniques.

Mathieu Brodeur, PhD, is studying how the brain uses information to find, recognize, and recall objects in a particular setting.

John Breitner, MD, has devoted his career to investigating factors that modify an individual’s risk of developing Alzheimer's Disease.

Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Marc Laporta, MD, develops international collaborative ventures  in the area of emergencies and disasters for the Americas.

As a clinician, Johanne Renaud holds the title of medical chief for the youth section of the Douglas Institute’s Depressive Disorders Program.

Reut Gruber examines the association between sleep and attention in children and adolescents and the genetics of sleep.

The research of Myra Piat focuses on housing for persons with serious mental illness and recovery from serious mental illness.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.